Shift Bioscience

Cell rejuvenation to rewind age driven diseases.

Cambridge, United Kingdom · $16.0M raised

Headquarters
Cambridge
Employees
1–10
Business Model
B2B
Total Funding
$16.0M
Last Round
$16.0M SeedOct 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Shift Bioscience is targeting the underlying cause of age driven diseases, the aging cell. Shift Bioscience has combined a novel aging clock (AC4) and virtual cell model to remove the primary bottleneck for discovery of cellular aging and rejuvenation targets, experimental throughput. This enables the discovery of hundreds of novel targets including those linked to disease states. Its product is an anti-fibrotic siRNA therapeutic for cell rejuvenation, and SB101 knockdown reverses epigenetic aging clocks in multiple cell types.

Summary

Shift Bioscience is a Biotech company based in Cambridge, United Kingdom. It has raised $16.0M in total across 1 round, most recently a $16.0M Seed round in Oct 2024. Investors include BGF, F-Prime Capital and Kindred Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundOct 2024
$16.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Shift Bioscience on Indexed.vc
<a href="https://indexed.vc/companies/shift-bioscience"><img src="https://indexed.vc/api/badge/company/shift-bioscience" alt="Shift Bioscience on Indexed.vc" width="260" height="76" /></a>